If you or someone close to you underwent a colonoscopy, bronchoscopy, enteroscopy, gastroscopy, or ERCP procedure and later developed a serious infection, you are not alone. In many cases, the issue may not stem from anything the hospital did wrong.
Across the United States, patients have reported severe infections linked to contaminated Olympus medical scopes. Dozens of individuals have died, while many others have required hospitalization or developed dangerous, drug-resistant infections, even when medical staff followed proper cleaning procedures.
The concern does not lie with the hospital. Instead, attention has shifted to the device itself.
Olympus Medical Device Recall: Why These Scopes Were So Difficult to Properly Disinfect
Olympus holds a dominant share of the global gastrointestinal endoscope market, accounting for a large percentage of devices used worldwide. In the United States, Olympus duodenoscopes are widely used in ERCP procedures, which are performed hundreds of thousands of times each year.
The contamination issue centers on a small mechanical feature located at the tip of the scope. This component comes into direct contact with internal fluids during procedures and contains intricate internal structures.
After each use, biological material can remain inside these tight spaces. While standard sterilization methods are designed to reach all surfaces, the internal structure of this component makes complete disinfection difficult. Narrow gaps, seals, and moving parts can trap debris that cleaning tools and disinfectants may not fully reach.
In some situations, bacteria can persist within the device and form protective layers that make them even harder to eliminate. As a result, contamination may remain and potentially affect subsequent patients.
This distinction is critical. The issue is not improper cleaning by healthcare providers, but whether the design of the device allows contamination to continue despite proper handling.
Olympus Knew And Said Nothing: What Did The Company Know About Scope Contamination Risks?
Internal records, FDA findings, and materials uncovered through litigation indicate that Olympus had knowledge of these contamination concerns long before they became widely known.
- 2012 — Early Warning Signs Emerge: Hospitals in Europe began reporting infections associated with Olympus duodenoscopes, even when they followed the company’s cleaning guidelines. Olympus did not take significant corrective action at that time.
- 2013 — Direct Concerns Raised About Device Design: Virginia Mason Hospital in Seattle alerted Olympus that the design of the elevator channel made thorough sterilization extremely difficult. The company did not initiate a recall, implement a redesign, or provide broader warnings to other healthcare providers.
- 2014–2015 — Internal Awareness Grows: Evidence produced during litigation suggests that Olympus engineers and executives were aware of the extent of the contamination issue but delayed taking action due to concerns about cost and potential reputational damage.
- 2015 — Federal Attention Increases After Outbreaks: Following a major outbreak at UCLA, the FDA released a safety communication recognizing infection risks tied to duodenoscopes, even when they were properly reprocessed. No recall was issued.
- 2016 — Cleaning Guidance Is Revised: Olympus updated its reprocessing instructions, effectively acknowledging that earlier guidance, which hospitals had relied on for years, was not sufficient.
- 2022 — Regulatory Scrutiny Expands: The FDA issued a warning letter to an Olympus manufacturing facility in Japan, identifying deficiencies in design validation, manufacturing documentation, and adverse event reporting.
- 2025 — Enforcement Actions Continue:
- In January, Olympus issued an advisory related to a scope accessory linked to contamination concerns
- By June, the FDA restricted dozens of Olympus devices from entering the United States due to ongoing compliance issues.
Olympus Scope Infections: What Should You Do If You Suspect Your Illness Is Linked To A Procedure?
If you developed an infection after undergoing a scope procedure, it is important to take your symptoms seriously and act without delay. Even when medical providers follow established protocols, the source of the issue may still be tied to the device used during the procedure.
Start by considering the timing of your symptoms. Many patients begin experiencing complications within days or weeks following their procedure. In other cases, the connection may not be immediately clear.
You may want to take the next step if you experienced any of the following:
- Hospitalization due to an unexplained infection after your procedure
- Treatment involving IV antibiotics or prolonged care for a serious infection
- A diagnosis involving sepsis, organ complications, or resistant bacteria
- Notification from a hospital regarding potential exposure to contaminated equipment
- A later diagnosis of a transmissible or serious infection following your procedure
For example, a patient may undergo what appears to be a routine ERCP and then develop a severe infection requiring hospitalization shortly afterward. In another situation, a patient might receive a notification months later indicating possible exposure to contaminated medical equipment. In both scenarios, the underlying cause may be related to the device rather than provider error.
Because these cases often involve detailed medical timelines and complex product liability issues, having your situation reviewed can be an important next step. An attorney can examine your procedure history, diagnosis, and available records to determine whether your experience aligns with known risks.
Acting early can help preserve important evidence and protect your ability to pursue a claim.
Call Anapol Weiss today for a free consultation: 215-735-1130.
Disclaimer: This blog is intended for informational purposes only and does not establish an attorney-client relationship. It should not be considered legal advice. For guidance specific to your situation, please contact our office directly.
